The Weekly Summary

Post cover of terrorist attacksJuly 18th – July 24th                                 2016

In the general news, Europe was hit with a third major terrorist attack within a month when a jihadist shooter in a Munich, Germany McDonald’s murdered at least eight children Continue reading

Posted in - The Weekly Summary | Leave a comment

Review of combination immunotherapies seen at ASCO 2016

June 22, 2016- interviewed by Steven E. Greer, MD

We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, Continue reading

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The Daltrey Townshend teenage and young adult cancer center at UCLA

May 4, 2014- Interviewed by Steven E. Greer

More than 20 years ago, Roger Daltrey began forming special cancer units in the UK to treat patients in their teenage Continue reading

Posted in - Opinion, Oncology, Rehab, UCLA | Leave a comment

The Weekly Summary

Bastille day attacksJuly 13th – July 17th                                 2016

In the general news, France suffered a third major ISIS attack within 18-months as a mad Continue reading

Posted in - The Weekly Summary | Leave a comment

The Weekly Summary

FBI ComeyJuly 4th – July 12th                                 2016

In the general news, the nation lapsed into lawlessness. First, FBI Director Comey refused to recommend an indictment of Hillary Clinton for break laws involving classified information and Continue reading

Posted in - The Weekly Summary | Leave a comment

The Weekly Summary

Terror-attack-at-Ataturk-Airport-Istanbul-TurkeyJune 27th – July 3rd                                 2016

In the general news, after suffering setbacks in the battlefields of Iraq, ISIS claimed responsibility Continue reading

Posted in - The Weekly Summary | Leave a comment

Review of immunotherapy and targeted therapy

June 17, 2016- interviewed by Steven E. Greer, MD

We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to go over the Continue reading

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The new CDC guidelines for prescribing opioid pain pills

June 1, 2016- Interviewed by Steven E. Greer, MD

Pain pill prescriptions have quadrupled since the 1990’s as drug companies stepped up marketing and funded Continue reading

Posted in - JAMA, - NEJM, - Pharma, CDC, Emergency medicine, General surgery, Oncology, Psychology Psychiatry, Rehab, Spine surgery, Sports medicine | Leave a comment

The super shady methods of pricing generic drugs in America: case study- Sildenafil

Generic revatioMay 15, 2016- by Steven E. Greer, MD

The last I read, Teva and Mylan were not supposed to launch their approved generic of Viagra (sildenafil) Continue reading

Posted in - Generics, - Opinion, - Pharma, CMS, Congress, FDA | Leave a comment

How the FDA regulates compounding pharmacies

April 5, 2015- Interviewed by Steven E. Greer, MD

Few people knew what a compounding pharmacy was until a meningitis outbreak traced to the Continue reading

Posted in - Policy, FDA | Leave a comment

The bionic pancreas data

July 2, 2014- Interviewed by Steven E. Greer, MD

The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas” Continue reading

Posted in - Medical Devices, - NEJM, Boston University, Diabetes and endocrinology | Leave a comment

BRAF and MEK combos for melanoma

Update October 1, 2015- The FDA approved the use of two drugs, Opdivo and Yervoy, to treat metastatic melanoma, as we first discussed with Dr. Ribas last year.  Continue reading

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The MusiCorps benefit concert 2015

October 16, 2015- by Steven E. Greer, MD

We interviewed the Founder of MusiCorps, Arthur Bloom, and one of the musicians in the band, Continue reading

Posted in - Policy, NIH, Orthopedic surgery, Plastic surgery, Psychology Psychiatry, Trauma Surgery, VA Walter Reed | Leave a comment

The Who’s Teen Cancer Lounge at Sloan Kettering opens

March 18, 2016- by Steven E. Greer MD

The Memorial Sloan Kettering Cancer Center held a press day for its new teen lounge Continue reading

Posted in Memorial Sloan-Kettering, Oncology | Leave a comment

Interview with the CEO of Synthetic Biologics, Jeff Riley

February 8, 2016- Interviewed by Steven E. Greer, MD Continue reading

Posted in - Biotech, Gastroenterology and liver, Infectious disease, NIH | 1 Comment

Have state health commissioners dropped the ball?

With Obamacare exchange premiums increasing 7.5% year-over-year, this 2013 video is still relevant…. Continue reading

Posted in CMS, Congress | Leave a comment

How to establish a face transplant team

March 3, 2015- Interviewed by Steven E. Greer, MD

In Part 2 of our interview with Eduardo Rodriguez, MD, DDS, Chairman of Plastic Surgery at Continue reading

Posted in - Policy, NYU, Plastic surgery | Leave a comment

The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - Generics, FDA | Leave a comment

Interview with the CEO of Neovasc, Alexei Marko

Posted in - Medical Devices, Cardiology, FDA | Leave a comment

Interview with the CEO of Galena Biopharma about cancer vaccines

February 8, 2016- Interviewed by Steven E. Greer, MD Continue reading

Posted in - Biotech, Oncology | Leave a comment